Search results

• Site visit to Sederma Beauty Actives business in France

  17-18 March 2016: Croda International plc hosted a Capital Markets Event for analysts and investors at its Sederma facility near Versailles, France.

• Analyst consensus

  Consensus collated from estimates submitted by side-sell analysts on Croda International Plc.

• Our Board activity in 2025

  An update from Croda’s 2025 Annual Report on Board governance and culture, highlighting leadership, accountability and the values guiding long-term sustainable growth.

• Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture

  Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Croda named Britain’s Most Admired Chemicals Company for the tenth time, extending an exceptional record of sustained peer recognition

  20 January 2026: Croda International Plc has been named Britain’s Most Admired Chemicals Company for the tenth time, highlighting its leadership in smart science and high-performance ingredients.

• Croda at a glance

  At Croda, we are driven by our Purpose, to use smart science to create high-performance ingredients and technologies that improve lives.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Croda acquires research enterprise Enza Biotech

  Developing the next generation of renewable surfactants using carbohydrate-based chemistry.

• Behind the Science

  Discover how Croda’s high-quality ingredients, scientific expertise and sustainable innovation deliver end-to-end solutions that power growth across Consumer Care and Life Sciences.

• Meet the expert: Will Small, Research & Technology Specialist

  Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.

• Your ingredients partner powering health innovation

  Explore how Croda’s smart science, people and high-performance ingredients are shaping the future of Life Sciences and enabling safer, more sustainable innovation.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Sustainability Committee

  Responsible for global Group-wide engagement with our sustainability targets and providing guidance and support to sites, regions and sectors to develop plans to deliver our sustainability goals.

• Accessibility page

  Here is our Accessibility page

• Cookie Policy

  Here we list all Cookies used on this site

• C4C Lead via SnapEngage

  C4C Lead via SnapEngage

• Unsubscribe

  Unsubscribe from our promotional email lists

• Terms and condition page

  Here you can be updated on our Terms and conditions

• Industrial Specialties

  Industrial Specialties serves our retained businesses in coatings, textiles, fibers, water treatment, and niche industrial markets, providing essential formulation ingredients and sustainable solutions from key Croda manufacturing sites worldwide.

• Consumer Care

  Consumer Care combines our businesses closest to consumers, offering innovative, sustainable solutions for home care, beauty, personal care, and fragrance. Our expertise enables us to provide tailored formulations to meet global consumer demands.